DMD
2
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
Avidity BiosciencesAOC 1044
Sarepta TherapeuticsClassical conditioning task
Clinical Trials (2)
Total enrollment: 139 patients across 2 trials
Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping
Start: Jan 2024Est. completion: Jul 202739 patients
Phase 2Active Not Recruiting
Defining Outcome Measures for Behavioural and Emotional Problems in Dystrophinopathies
Start: Sep 2022Est. completion: Dec 2024100 patients
N/ARecruiting
Related Jobs
Director, Quality Assurance & Quality Systems
San Diego, CA
4d ago
$175K - $215K/yr
Sr. Medical Science Liaison-DMD (Duchenne Muscular Dystrophy)-Northwest
Remote
4d ago
Operations Coordinator
San Diego, CA
5d ago
$27 - $33/yr
Senior Director, Quality
San Diego, CA
5d ago
$210K - $260K/yr
Senior Pharmacometrician
Boston, MA
6d ago
$180K - $236K/yr
Senior Director, Managed Access Programs
Waltham, MA
1w ago
$233K - $285K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 139 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.